chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a healthcare worker refers to a patient of unknown gender and age. On 19-FEB-2015, the patient was vaccinated with an improperly stored (Oka/Merck) VARIVAX, (lot number) dose 1, 0.5 ml, subcutaneously. No adverse effects were reported. This is one of the three reports received from the same reporter. Additional information is not expected.
I got the 1st vaccine in Nov 2019 and for got to get the 2nd one; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in November 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
got the covid; got the covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID.  A 70-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetic" (unspecified if ongoing), notes: Diagnosed maybe, she doesn't know 2000 or around 1996. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got the covid". The patient underwent the following laboratory tests and procedures: Body height: (unspecified date) 5 foot 8 or 5 foot 9, notes: his height is about 5 foot 8 or 5 foot 9; Body temperature: (unspecified date) Fever around 99-101; SARS-CoV-2 test: (02Aug2023) Positive, notes: home test. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient started feeling sick on Wednesday, he was very sick Thursday and Friday and Saturday started getting better. Patient started feeling crummy with a little coughing and little runny nose Wednesday and by end of day felt worse and had sticks up the nose, and he did and had a fever. He tested positive. Thursday and Friday he was very sick. Saturday he was feeling a little better. Now has a little coughing little sneezing. They got Mucinex liquid, take a cup and helps with coughing and sneezing. It's a big help. Wednesday he was at work and figured he had a little cough and runny nose until he felt worse. Got fever around 99-101. He tested positive for Covid by home test on Wednesday 02Aug2023. He was given prescription Paxlovid but started feeling better and didn't take it. He is diabetic and on a lot of those medications but doesn't know names of them.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300272391 same patient, different vaccine doses/event;US-PFIZER INC-202300272392 same patient, different vaccine doses/event;US-PFIZER INC-202300271922 same reporter/AE/vaccine,different patients;
That Friday night I had a runny nose, sore throat and I was coughing. All of that worsened on Saturday. On Sunday, I thought I might be better but I was really tired. My friend told me to test and I tested positive for COVID-19. I started taking PAXLOVID on Monday, and I was very exhausted and my muscles hurt for Monday through Wednesday (3 days). Also, another strange occurrence. I've traveled a few times and in security, they've had to check my arm where the vaccination was administered due to the metal detector. That has happened a few times now. Kind of strange.
This non-serious initial spontaneous case, was received from pharmacist on 04-Oct-2017, concerning an elderly male patient of an unspecified age. The patient's current condition included mild dementia (since an unspecified date). The patient's historical drug included unspecified influenza vaccine (was given a month before) (as reported). On an unspecified date, the patient was administered with influenza vaccine (dose, batch number, expiry date, manufacturer, trade name, route of administration and anatomical location: not reported). The patient's wife reported that, her elderly husband was given second flu shot, for that pharmacist checked and found that her husband had mild dementia, and he did not remember that one vaccine was already given to him a month before (explicitly coded as inappropriate schedule of vaccine administered). Also, the patient's record was not checked prior to the latest injection.
Developed reactive arthritis. Beginning four days after the shot, my joints started to severely ache. Within another week my ankle swelled up. My wrists, ankles, knee, and shoulder are all still sore. I?ve been unable to do my normal activities. My doctor prescribed me a course of prednisone on 3/12/21 and agreed I should not get the second shot.
Confirmed dx of chickenpox. 20-30 pox noted to pt's abdomen, back and groin. The pt received Varivax on 3/21/97.
Late evening of day she received vaccines, developed fever, left deltoid redness, swelling and warm to touch and soreness.
Fever 102 onset Tues swelling at site noted local at injection site. No fever 3rd day but swelling; hardness and redness persist.
Incrased temp and erythema surrounding injections site 3-4cm in circumference; increased warmth of arm. No lymph nodes noted on knee or groin. Temp 100.5, pulse 120 resp 24.
G40.909 EPILEPSY, UNSPECIFIED 4/2/2021 PNEUMONIA J96.00 ACUTE RESPIRATORY FAILURE 6/21/2021 PNEUMONIA J96.10 CHRONIC RESPIRATORY FAILURE 6/21/2021 PNEUMONIA G40.909 EPILEPSY, UNSPECIFIED 4/2/2021 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 6/21/2021 ACUTE RESPIRATORY FAILURE J96.10 CHRONIC RESPIRATORY FAILURE 6/21/2021 ACUTE RESPIRATORY FAILURE
Pt recvd vax & 3 days following the vax exp myalgias, sweating, lightheadedness, chills & shaking; later devel a rash & ear pain; No further details were provided
Patient hospitalized for ventricular tachycardia within 6 weeks of receiving COVID vaccination.
The patient arrived at the clinic to get his schedule flu vaccination shot and covid booster shot. He filled out and signed his consent forms for both covid and flu shots.   Pt received 2 influenza 0.5ml doses IM route to his R. deltiod.  Afluria lot #AS3513B exp. 5/31/23, Flurarix lot #5ES77exp. 6/30/23  He did NOT receive his Covid booster vaccine.
Swollen, red, extremely itchy rash that started at the injection site and spread across my upper arm to lower bicep. It was initially bumpy closest to the injection, but after about 12 hours, no longer is. After 24hrs it?s very red still on the outer area, and this is the itchiest part. The injection is still quite firm and more painful to the touch.
had side effects a little bit longer than she did; arm pain; redness and pain for longer than she experienced; pain for longer than she; something weird; ran a fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had side effects a little bit longer than she did), PAIN IN EXTREMITY (arm pain), ERYTHEMA (redness and pain for longer than she experienced), PAIN (pain for longer than she) and FEELING ABNORMAL (something weird) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had side effects a little bit longer than she did), PAIN IN EXTREMITY (arm pain), ERYTHEMA (redness and pain for longer than she experienced), PAIN (pain for longer than she), FEELING ABNORMAL (something weird) and PYREXIA (ran a fever). At the time of the report, VACCINATION COMPLICATION (had side effects a little bit longer than she did), PAIN IN EXTREMITY (arm pain), ERYTHEMA (redness and pain for longer than she experienced), PAIN (pain for longer than she), FEELING ABNORMAL (something weird) and PYREXIA (ran a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information was provided.
This case was reported by a healthcare professional (medical assistant) and described the occurrence of elevated renal function in a 27-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent vaccination included ENGERIX B ;GlaxoSmithKline;unknown;unknown given on an unspecified date. On 5 January 2013 the subject received 2nd dose of ENGERIX B (.5 ml, unknown route, left arm) and experienced vaccine underdose. The subject received less than the indicated dose for ENGERIX B. On 5 January 2013, less than one month after vaccination with ENGERIX B, the subject experienced elevated renal function. On 4 February 2013, 30 days after vaccination with ENGERIX B, the subject experienced hbsag positive (hepatitis). The medical assistant reported that the subject's "kidney function has been elevated and HBsAg came back positive yesterday [4 February 2013]." This case was assessed as medically serious by GSK. Relevant test results included a positive hepatitis b surface antigen test on 4 February 2013 and nonspecific abnormal results of function study of kidney. At the time of reporting the outcome of the events were unspecified.
Approx 15  minutes after receiving her second Pfizer vaccine she started c/o stiffness in neck progressing to a headache. she was started on oxygen. 1055 she started c/o tightness in chest. Epinephrine was administered. EMSA called. Client was transported to ER. I have called this client 7 times and sent a letter and she has not responded to me.
Sore Arm: Runny nose: watery eyes: cough: scratchy throat: headache: chills place on Paxlovid
Vomiting; This is a spontaneous report from a non-contactable nurse (patient). A 32-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), via an unspecified route of administration in left arm, on 07Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital. On 07Jan2021, the patient started vomiting 12 hours after injection. The event was considered non-serious. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The patient was recovering from the event.  No follow-up attempts are possible. No further information is expected.
Red swelling around site of injection one week after shot. Red patch grew to about 3 inches at widest section before shrinking back down. Mild itching. One day of entire upper arm being swollen.
none noted - no obvious signs/symptoms Gardasil not indicated for 5 mo. baby, inadvertently given in place of Prevnar.
Information was received on 11-JUL-2017 from a pharmacist who is also the patient. No concomitant medications were reported. Patient was reported to be 13 weeks pregnant. On 11-JUL-2017, while the pharmacist was administering a dose of ZOSTAVAX (lot # N013289, expires 04-JUL-2018) (dose, route and site not reported) reconstituted with sterile water diluent (lot L033143, expires 16-APR-2018), "the tip of the plastic syringe and the needle separated while administering [the vaccine] and the ZOSTAVAX splashed into my eyes, mouth and face and I am 13 weeks pregnant." The pharmacist confirms that the full dose was not administered to the intended patient (MARRS # 1707USA009340). No adverse effects reported. No further information was provided. Additional information has been requested. This is one of two reports from the same reporter.
COLD; she is sneezing a lot; SHE HAS A SORE THROAT; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (COLD), SNEEZING (she is sneezing a lot) and OROPHARYNGEAL PAIN (SHE HAS A SORE THROAT) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, ATORVASTATIN, PANTOPRAZOLE and METFORMIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced NASOPHARYNGITIS (COLD), SNEEZING (she is sneezing a lot) and OROPHARYNGEAL PAIN (SHE HAS A SORE THROAT). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, NASOPHARYNGITIS (COLD), SNEEZING (she is sneezing a lot) and OROPHARYNGEAL PAIN (SHE HAS A SORE THROAT) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Right arm red and slightly swollen. Nontender right arm. Started 5/22/04 after 3pm.
pt recv vax 1993 & 20SEP93 pt devel a measles look on abd area that remained for 3yr;cool air & water caused pt to break out in blistering rash;
severe injection site soreness, headache and neck pain advised patient to take regular strength tylenol as needed and ice pack
Patient fainted and hit her head on floor of gym. All vital signs are normal. She has anxiety and bee allergies. Patient fainted for 30 seconds
Migraine lasting for 10 hours,  vomiting, diarrhea, nausea, chills. Took ibuprofen, stayed in bed. Still have nausea and migraine today. Tested positive for Covid 03/01/2021. Also had Covid 11/19/2021
mom returned to clinic approx 15min p/vax & child's arm @ site of MMR was red & swelling;ice bag put on arm fro next few minutes & child monitored;In no distress or pain;mom advised to watch & take to ER if problems;
Numbness and tingling to Bil upper and lower extremities.    Narrative: pt has a hx of neuropathy and states he feels that it came on after vaccination.
Red blotches; warm to the touch; was swollen; the injection site was itching a lot; headache; injection site had a rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Red blotches), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE SWELLING (was swollen), VACCINATION SITE PRURITUS (the injection site was itching a lot) and HEADACHE (headache) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METOPROLOL for an unknown indication.    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced RASH MACULAR (Red blotches), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE SWELLING (was swollen), VACCINATION SITE PRURITUS (the injection site was itching a lot), HEADACHE (headache) and VACCINATION SITE RASH (injection site had a rash). The patient was treated with IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE (ADVIL COLD) at an unspecified dose and frequency and CHLORPHENAMINE MALEATE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (SINUS [CHLORPHENAMINE MALEATE;PARACETAMOL;PSEUDOEPHEDRINE HYDROCHLORIDE]) for Headache, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Red blotches), VACCINATION SITE WARMTH (warm to the touch), VACCINATION SITE SWELLING (was swollen), VACCINATION SITE PRURITUS (the injection site was itching a lot), HEADACHE (headache) and VACCINATION SITE RASH (injection site had a rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Twenty-four hours after receiving Moderna (2nd shot), I had terrible brain zaps.  I had to lie still and try to avoid any movement, including my eyes.  For my booster,, I chose Pfizer, hoping to avoid the previous reaction; however, 24 hour later the same occurred.  I just think it is important for you to know; I also informed my psychiatrist, who had not heard of this.  These brain zaps were pretty severe, nonstop, and required me to lie still in bed for hours.  They stayed with me for about 8 hours.
patient didn´t receive 2nd dose/ 9 months before of 1st dose; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date; 9 m onths ago prior to reporting.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follows:  The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient received 1st dose 9 months prior to reporting. The healthcare professional (HCP) asked how to proceed if patient did not received 2nd dose. The reporter consented to follow up.
Fever with in 3-4 hours after receiving IMOVAX; nausea; Rethergy, general aching; lack of appetite; shaking tremors started 24 hours later and continued for 4 days.  Minor injection site redness, soreness and warmth at injection site.  No hives, no edema, no sob, saw pcp on day 4.  Benadryl on administred. improvement noted with in hours.  Occasional sparadic jerking on day 5. day 6 returned to normal - no tremors. The follow up received on 6/25/01 stated, "client completed series of Rabies vaccine and Benadryl per oral prior to each dose. No adverse rreactions noted. 6/15/01, pt's current medical condition returned to normal." This case is closed.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Other HCP) from product quality group. The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Sep2022 as dose 4 (booster), single (Lot number: GJ5342) at the age of 42 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 29Dec2020 as dose 1, single (Lot number: EL0140), in right arm, on 20Jan2021 as dose 2, single (Lot number: EL9263), in right arm and on 04Oct2021 as dose 3 (booster), single (Lot number: FE3592), in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Tested positive 3 days after testing negative with a return of symptoms; Negative, notes: Tested positive 3 days after testing negative with a return of symptoms. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Tested positive 3 days after testing negative with a return of symptoms. product: COVID 19 Treatment, brand: Paxlovid, treatment start date: 29Nov2022, treatment stop date: 03Dec2022.; Sender's Comments: Based on the available information and close temporal association, a possible causal relationship cannot be excluded between the suspect vaccine BNT162b2 and the reported events "vaccination failure", "COVID-19".
Arm pain for almost a week. Tiredness, headache, muscle pain strong during long time, chills during long period, fever during 2 days, nausea.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was reported. On multiple unspecified dates, the patients were vaccinated with improperly stored (temperature 23.7 Fahrenheit degrees (F), time frame reported as cumulative total of 14 hours and 45 minutes, also reported as vaccine temperature excursion) doses of VARIVAX (Merck) injection (lot# L027288 with expiration date 21-JUL-2017, lot# L026411 with expiration date 15-FEB-2017, lot# L018001 with expiration date 19-MAY-2017, lot# L031065 with expiration date 18-AUG-2017, lot# L044526 with expiration date 09-NOV-2017 and lot# L020003 with expiration date 02-JUN-2017, dose and route of administration were not reported). No adverse effect was reported. There was no previous temperature excursion. The call was made because of data logger. This is one of two reports received from the same reporter. Additional information has been requested.
He lives by himself and he has not been eating a meal since his flu shot on Friday. He did not drink any meaningful amount of liquid at home. He came to the clinic but he collapsed before he got to the check in area. His head hit the floor. He felt lightheaded while waiting to go into the room. Pe dry oral mucosa; H 131-BP 60-70; Chest clear he is able to eat and BP 120/70 with HR around 90-100 after 2 liters of iv fluid advise him to continue on po intake.  6/8/07 Received medical records from hospital (most of which were chemo or portacath records) which reveal patient experienced fever & myalgia along w/poor appetite s/p flu shot on 11/17.  Patient lives alone & had been unable to eat or drink much since 11/17.  Had productive cough of yellow sputum.  Brought to clinic by family member because he was very tired & unable to manage at home.  Patient collapsed before he got to check in area & hit his head.  He had felt lightheaded.  Treated w/IVF x 2L, felt better & was d/c to home.
Chest pain, Shortness of breathe, elevated blood pressure, rash & swelling on right hand, sweating, fast heartbeat.
REDNESS, SWELLING WITH A KNOT WITHIN 24 HOURS OF RECEIVING THE SHOT. RECOMMENDED ANTIHISTAMINE AND TYLENOL. THE PATIENT WILL BE SEEING BY PCP ON JANUARY 2021.